Applications from the field of Pharma & Biopharma from Agilent Technologies | LabRulez ICPMS

The determination of the palladium content in valacyclovir hydrochloride using an Agilent 720 ICP-OES according to USP 35

Applications

| 2013 | Agilent Technologies

ICP/OES

Instrumentation

ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Trace level analysis of sulfur, phosphorus, silicon and chlorine in NMP using the Agilent 8800 Triple Quadrupole ICP-MS

Applications

| 2013 | Agilent Technologies

ICP/MS, ICP/MS/MS

Instrumentation

ICP/MS, ICP/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Using Heteroatoms as “Natural Labels” in the Quantitative Analysis of Active Pharmaceutical Ingredients by HPLC-ICP-MS

Applications

| 2021 | Agilent Technologies

HPLC, ICP/MS, Speciation analysis, ICP/MS/MS

Instrumentation

HPLC, ICP/MS, Speciation analysis, ICP/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Alternative sample preparation and analysis approach for ICH/USP controlled metals by ICP-MS

Posters

| N/A | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Agilent ICP-MS Journal (August 2013 – Issue 54)

Others

| 2013 | Agilent Technologies

Software, HPLC, ICP/MS, Speciation analysis

Instrumentation

Software, HPLC, ICP/MS, Speciation analysis

Manufacturer

Agilent Technologies

Industries

Environmental, Pharma & Biopharma

Agilent SLIMS for Pharmaceutical Laboratories

Brochures and specifications

| 2021 | Agilent Technologies

Software

Instrumentation

Software

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

A novel ICP-MS/MS approach for the analysis of vanadium in glucose magnesium sulfate injection to meet the requirement of USP<232>/<233>

Posters

| 2019 | Agilent Technologies (ASMS)

ICP/MS, ICP/MS/MS

Instrumentation

ICP/MS, ICP/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Semiquantitative Screening of Pharmaceutical Antiviral Drugs using the Agilent 7500ce ICP-MS in Helium Collision Mode

Applications

| 2017 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Extractable and Leachable Metals in Plastic Materials used for Drug Products by ICP-OES

Applications

| 2021 | Agilent Technologies

ICP/OES

Instrumentation

ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS

Applications

| 2021 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma from Agilent Technologies | LabRulez ICPMS

The determination of the palladium content in valacyclovir hydrochloride using an Agilent 720 ICP-OES according to USP 35

Trace level analysis of sulfur, phosphorus, silicon and chlorine in NMP using the Agilent 8800 Triple Quadrupole ICP-MS

Using Heteroatoms as “Natural Labels” in the Quantitative Analysis of Active Pharmaceutical Ingredients by HPLC-ICP-MS

Alternative sample preparation and analysis approach for ICH/USP controlled metals by ICP-MS

Agilent ICP-MS Journal (August 2013 – Issue 54)

Agilent SLIMS for Pharmaceutical Laboratories

A novel ICP-MS/MS approach for the analysis of vanadium in glucose magnesium sulfate injection to meet the requirement of USP<232>/<233>

Semiquantitative Screening of Pharmaceutical Antiviral Drugs using the Agilent 7500ce ICP-MS in Helium Collision Mode

Analysis of Extractable and Leachable Metals in Plastic Materials used for Drug Products by ICP-OES

Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS

Related content

From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

Cryo-EM structures show how Trypanosomes escape the human innate immune response

An innovative approach to planar chiral substances